The Bridge Project:
David H. Koch Institute for Integrative Cancer Research at MIT and Dana-Farber/Harvard Cancer Center
In 2012, the National Brain Tumor Society became a funding partner in the Bridge Project being conducted by the David H. Koch Institute for Integrative Cancer Research at MIT and Dana Farber/Harvard Cancer Center. The Bridge Project is an unprecedented research collaboration that brings researchers and clinicians together with the goal of solving the most complex challenges in cancer research and care, starting with two lethal cancers: pancreatic and brain (glioblastoma). Koch Institute and Dana Farber/Harvard researchers are collaborating to develop new tools and methods in cross-disciplinary environments involving, for instance, engineers, cancer biologists, and clinical oncologists.
The Bridge Project research program for glioblastoma is:
“Single-cell functional, genomic and transcriptomic analysis in glioblastoma,” a collaboration between Keith L. Ligon of Dana-Farber, J. Christopher Love of Koch Institute, and Matthew Meyerson of Dana-Farber and the Broad Institute.
The first grant recipients were selected on the basis of greatest potential to generate high-impact clinical outcomes.
